Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Gregory R Mundy

Showing results (1-10 of 68) with videos related to

Pageof 7
Sort By:
Proceedings of the National Academy of Sciences of the United States of America|September 10, 2003
Endothelin-1 and osteoblastic metastasisGregory R Mundy
Oncology (Williston Park, N.Y.)|June 19, 2004
The evolving role of bisphosphonates: cancer treatment-induced bone lossGregory R Mundy
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|August 1, 2002
Bisphosphonates and tumor burdenGregory R Mundy
Nutrition Reviews|February 5, 2008
Osteoporosis and inflammationGregory R Mundy
Bone|May 2, 2006
In memoriam; Dr. Gideon RodanGregory R Mundy
Nature Clinical Practice. Oncology|November 3, 2005
How can bone turnover markers be best utilized for prediction of skeletal events in patients with solid tumors?Gregory R Mundy
Nature Reviews. Cancer|August 3, 2002
Metastasis to bone: causes, consequences and therapeutic opportunitiesGregory R Mundy
Annual Review of Medicine|January 31, 2002
Directions of drug discovery in osteoporosisGregory R Mundy
The American Journal of Clinical Nutrition|February 14, 2006
Nutritional modulators of bone remodeling during agingGregory R Mundy
Cell|August 12, 2006
Boning up on ephrin signalingGregory R Mundy, Florent Elefteriou
Pageof 7

Showing results (1-10 of 68) with videos related to

Sort By:
Pageof 7
Proceedings of the National Academy of Sciences of the United States of America|September 10, 2003
Endothelin-1 and osteoblastic metastasisGregory R Mundy
Oncology (Williston Park, N.Y.)|June 19, 2004
The evolving role of bisphosphonates: cancer treatment-induced bone lossGregory R Mundy
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|August 1, 2002
Bisphosphonates and tumor burdenGregory R Mundy
Nutrition Reviews|February 5, 2008
Osteoporosis and inflammationGregory R Mundy
Bone|May 2, 2006
In memoriam; Dr. Gideon RodanGregory R Mundy
Nature Clinical Practice. Oncology|November 3, 2005
How can bone turnover markers be best utilized for prediction of skeletal events in patients with solid tumors?Gregory R Mundy
Nature Reviews. Cancer|August 3, 2002
Metastasis to bone: causes, consequences and therapeutic opportunitiesGregory R Mundy
Annual Review of Medicine|January 31, 2002
Directions of drug discovery in osteoporosisGregory R Mundy
The American Journal of Clinical Nutrition|February 14, 2006
Nutritional modulators of bone remodeling during agingGregory R Mundy
Cell|August 12, 2006
Boning up on ephrin signalingGregory R Mundy, Florent Elefteriou
Pageof 7